Company description

ARWR, or Arrowhead Pharmaceuticals, is a biopharmaceutical company focused on developing innovative medicines for the treatment of intractable diseases. The company utilizes its proprietary Targeted RNAi Molecule (TRiM™) platform to design and develop therapies that silence specific genes responsible for various diseases. Their research and development efforts are primarily centered on RNA interference (RNAi) therapies, which have the potential to target a wide range of diseases including liver, lung, and rare diseases. ARWR's pipeline consists of multiple drug candidates in clinical and preclinical stages, each with the potential to address serious and often life-threatening conditions. Along with their own internal programs, they also have collaborations with major pharmaceutical companies to advance their RNAi platform. With a focus on innovative and precise therapeutic solutions, ARWR is dedicated to providing hope and improved outcomes for patients with unmet medical needs.